In addition to conducting our own cancer clinical trials and research, the Lahey Health Cancer Institute (LHCI) also provides broad access to colorectal clinical trials in the greater Boston area. This allows you to participate in the latest research without having to journey far from home.
Lahey Health is conducting leading-edge research on colorectal cancer and looking for biomarkers using blood samples to help develop targeted therapies for our patients.
A deeper understanding of how cancer forms and grows has led to more targeted treatment options today than ever before – especially for people with rare or hard-to-treat cancers, or those whose cancer did not respond adequately to conventional treatments.
LHCI researchers are involved in a clinical trial that is examining the role of radiation therapy in colorectal cancer, and whether it could be replaced by less toxic treatments. Another project involves studying colorectal cancer in the elderly, to analyze risk factors and consider whether surgery is the best treatment option in this population.
When you participate in a cancer clinical trial, you can be assured that your safety is our primary concern. Our clinical staff has extensive experience in conducting clinical trials, and we are deeply committed to protecting the rights and welfare of our patients.
All research activity at Lahey Health is monitored by the hospital’s Institutional Review Board (IRB) to ensure the safety of study participants. The IRB is composed of Lahey Health colleagues and members of the general public from our community as well.
If you are interested in participating in a colorectal cancer clinical trial, just speak with your doctor or patient navigator.